Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|August 1, 2012
Genetic testing by cancer site: skinMichele Gabree, Meredith SeidelCurrent Treatment Options in Oncology|March 22, 2014
Clinical applications of melanoma geneticsMichele Gabree, Devanshi Patel, Linda RodgersSeminars in Cutaneous Medicine and Surgery|November 6, 2010
Genetic determinants of cutaneous melanoma predispositionDurga Udayakumar, Bisundev Mahato, Michele Gabree, et al.Cancer Genetics|October 4, 2011
Which individuals undergoing BRACAnalysis need BART testing?Kristen M Shannon, Linda H Rodgers, Gayun Chan-Smutko, et al.Plos One|May 1, 2012
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma familiesChing-Ni Jenny Njauw, Ivana Kim, Adriano Piris, et al.JAMA Oncology|August 14, 2015
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk AssessmentAndrea Desmond, Allison W Kurian, Michele Gabree, et al.The Oncologist|February 1, 2024
Development of an Electronic Decision Aid Tool to Facilitate Mainstream Genetic Testing in Ovarian Cancer PatientsKristen M Shannon, Devanshi Patel, Jessica M Jonas, et al.NPJ Precision Oncology|March 6, 2020
Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genesTyler Landrith, Bing Li, Ashley A Cass, et al.American Journal of Human Genetics|January 2, 2018
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848Magdalena Koczkowska, Yunjia Chen, Tom Callens, et al.Pageof 1